Coherus Oncology, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Coherus Oncology, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 35.50K shares.
- Coherus Oncology, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 1.70M shares, a 97.32% increase from fiscal 2019.
- Coherus Oncology, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2019 was 863.94K shares, a 81.11% increase from fiscal 2018.
- Coherus Oncology, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2018 was 477.02K shares, a 192.69% increase from fiscal 2017.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 35.50K shares 10-K · filed 2026-03-09 | |
| 2024-12-31 | 174.65K shares 8-K · filed 2025-11-13 | |
| 2020-12-31 | 1.70M shares 10-K · filed 2021-02-25 | |
| 2019-12-31 | 863.94K shares 10-K · filed 2020-02-27 | |
| 2018-12-31 | 477.02K shares 10-K · filed 2019-02-28 | |
| 2017-12-31 | 162.98K shares 10-K · filed 2018-03-08 | |
| 2016-12-31 | 761.59K shares 10-K · filed 2017-03-14 | |
| 2015-12-31 | 861.14K shares 10-K · filed 2016-02-29 | |
| 2014-12-31 | 48.41K shares 10-K · filed 2015-03-23 | |
| 2013-12-31 | 3.25K shares 10-K · filed 2015-03-23 | |
| 2012-12-31 | 22.31K shares 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |